We recommend starting at age 1, once your pet’s body has fully matured.

NAD⁺ levels—which support energy, repair, and healthy aging—start declining around age 2 in cats and age 3 in dogs. Early support helps slow that drop.

Hollywood Elixir isn’t suitable for kittens or puppies under 1 year, whose needs are different during growth.

Yes. All La Petite Labs supplements are designed to work safely together.

Hollywood Elixir pairs especially well with our skin, coat, and gut support formulas—offering layered care for aging pets.

Most pet supplements stop at basics. Hollywood Elixir targets deeper threats—like oxidative stress and NAD+ decline—using a clinically advanced blend of 16 longevity actives.

Every ingredient is human-grade, NSF® tested, and free from fillers. Just clean, powerful science in a daily sachet.

Hollywood Elixir is lactose-free and made with grass-fed whey protein isolate. Its current flavor includes chicken and fish—well-loved by most pets, but unsuitable for those with sensitivities. We’re working on alternative flavors like rabbit and kangaroo.

Hollywood Elixir features real free-range chicken—muscle, liver, and bone—for a rich, whole-prey flavor. Seaweed and fish powder add a gourmet finish. No artificial flavorings. Rabbit and kangaroo options are coming soon.

Hollywood Elixir supports healthy aging from the inside out. Its antioxidant-rich, NAD+-boosting blend helps protect cells, ease inflammation, and sustain memory, energy, and immunity in adult and senior pets. Designed for pet parents who want to give their animals more good years.

Most pets love it. In taste tests with both cats and dogs, Hollywood Elixir was eagerly eaten when mixed into wet food. For picky eaters, try blending in a small amount first, then add the rest. We’re also exploring new flavors like rabbit and kangaroo to suit more preferences.

Results unfold gradually — not as sudden transformations, but as quiet gifts. Most pet parents tell us they feel the difference before they see it.

1 Month

More energy in the mornings. A softening of the fog.

They lift their head when you say their name.

3 Months

Brighter eyes. Calmer moods. Fewer off days.

They walk beside you a little longer.

6 Months

Fewer sick days. Clearer memory. Stronger steps.

They come when you call, with more joy in the greeting.

12 Months and Beyond

The fading slows. The light stays.

They're still here — fully here — for a little while longer.

Most pet parents notice early changes within 4–6 weeks — more energy, clearer eyes, a bit more spring in their step.

By 3–6 months, the deeper benefits emerge: steadier moods, fewer sick days, stronger recall.

Not every shift is visible — but many are felt. A sense that they’re more here with you.

Yes. Our supplements are formulated in a facility that meets FDA regulations, follows cGMP guidelines, and is ISO 22000 certified. For added peace of mind, the Hollywood Elixir is also third-party tested by NSF®.

No, not when used as directed. Each sachet contains vet-approved doses well within safe limits. That said, we recommend storing sachets out of reach of children and pets—just like any supplement.

If your pet is over 1 year old and slowing down—less playful, more tired, getting sick more often, or seeming “not quite themselves”—Hollywood Elixir can help. It’s especially valuable for adult and senior pets facing the natural wear of aging.

Yes. We offer a 7-day return policy. If your order arrives damaged, defective, or incorrect, please contact us right away. Returns are processed through our facility in Texas. For full details, visit our Returns Policy or email us at hello@lapetitelabs.com.

Read More

[1] Lobo V, Patil A, Phatak A, Chandra N (2010) Free radicals, antioxidants and functional foods: impact on human health. Pharmacogn Rev 4:118–126

[2] Ashok BT, Ali R. The aging paradox: Free radical theory of aging.Exp Gerontol.1999;34:293–303.

[3] Cantuti-Castelvetri I, Shukitt-Hale B, Joseph JA. Neurobehavioral aspects of antioxidants in aging.Int J Dev Neurosci.2000;18:367–81.

[4] Yang H, Leng J, Liu N, Huang L. Editorial: Free radicals and antioxidants in diseases associated with immune dysfunction, inflammatory process, and aberrant metabolism. Front Endocrinol (Lausanne). 2024 Jan 16;15:1363854. doi: 10.3389/fendo.2024.1363854. PMID: 38298379; PMCID: PMC10825471.

[5] Ebadi M.Antioxidants and free radicals in health and disease: An introduction to reactive oxygen species, oxidative injury, neuronal cell death and therapy in neurodegenerative diseases.Arizona: Prominent Press; 2001.

[6] Peoples JN, Saraf A, Ghazal N, Pham TT, Kwong JQ. Mitochondrial dysfunction and oxidative stress in heart disease. Exp Mol Med. 2019 Dec 19;51(12):1-13. doi: 10.1038/s12276-019-0355-7. PMID: 31857574; PMCID: PMC6923355.

[7] Cholia R.P., Kumari S., Kumar S., Kaur M., Kaur M., Kumar R., Dhiman M., Mantha A.K. An in vitro study ascertaining the role of H2O2 and glucose oxidase in modulation of antioxidant potential and cancer cell survival mechanisms in glioblastoma U-87 MG cells.Metab. Brain Dis.2017;32:1705–1716. doi: 10.1007/s11011-017-0057-6.

[8] Bentz B. Head and neck squamous cell carcinoma as a model of oxidative-stress and cancer.J. Surg. Oncol.2007;96:190–191. doi: 10.1002/jso.20817.

[9] Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact. 2006 Mar 10;160(1):1-40. doi: 10.1016/j.cbi.2005.12.009. Epub 2006 Jan 23. PMID: 16430879.

[10] Lautrup S, Hou Y, Fang EF, Bohr VA. Roles of NAD+in Health and Aging. Cold Spring Harb Perspect Med. 2024 Jan 2;14(1):a041193. doi: 10.1101/cshperspect.a041193. PMID: 37848251; PMCID: PMC10759992.

[11] Navas LE, Carnero A. NAD+metabolism, stemness, the immune response, and cancer. Signal Transduct Target Ther. 2021 Jan 1;6(1):2. doi: 10.1038/s41392-020-00354-w. PMID: 33384409; PMCID: PMC7775471.

[12] Lautrup S, Sinclair DA, Mattson MP, Fang EF. NAD+in Brain Aging and Neurodegenerative Disorders. Cell Metab. 2019 Oct 1;30(4):630-655. doi: 10.1016/j.cmet.2019.09.001. PMID: 31577933; PMCID: PMC6787556.

[13] Wang X, He HJ, Xiong X, Zhou S, Wang WW, Feng L, Han R, Xie CL. NAD+in Alzheimer's Disease: Molecular Mechanisms and Systematic Therapeutic Evidence Obtainedin vivo. Front Cell Dev Biol. 2021 Aug 3;9:668491. doi: 10.3389/fcell.2021.668491. PMID: 34414179; PMCID: PMC8369418.

[14] Perez-Sanchez C, Escudero-Contreras A, Cerdó T, Sánchez-Mendoza LM, Llamas-Urbano A, la Rosa IA, Pérez-Rodriguez M, Muñoz-Barrera L, Del Carmen Abalos-Aguilera M, Barbarroja N, Calvo J, Ortega-Castro R, Ruiz-Vilchez D, Moreno JA, Burón MI, González-Reyes JA, Collantes-Estevez E, Lopez-Pedrera C, Villalba JM. Preclinical Characterization of Pharmacologic NAD+Boosting as a Promising Therapeutic Approach in Rheumatoid Arthritis. Arthritis Rheumatol. 2023 Oct;75(10):1749-1761. doi: 10.1002/art.42528. Epub 2023 Jul 28. PMID: 37094367.